A Shield Against Infection: The Promising Development of Monoclonal Antibodies for Immediate Protection
A highly promising, non-traditional approach to malaria prevention is the development of long-acting monoclonal antibodies (mAbs). Unlike vaccines, which prime the immune system to generate its own defense over time, mAbs provide immediate, passive immunity by directly injecting ready-made, laboratory-produced antibodies into the body. Monoclonal antibodies, such as MAM01, are engineered to...
0 Kommentare 0 Anteile 15 Ansichten 0 Vorschau